357 related articles for article (PubMed ID: 25976012)
21. Emerging anticoagulant strategies.
Fredenburgh JC; Gross PL; Weitz JI
Blood; 2017 Jan; 129(2):147-154. PubMed ID: 27780803
[TBL] [Abstract][Full Text] [Related]
22. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
[TBL] [Abstract][Full Text] [Related]
23. The many faces of the contact pathway and their role in thrombosis.
Woodruff RS; Sullenger B; Becker RC
J Thromb Thrombolysis; 2011 Jul; 32(1):9-20. PubMed ID: 21404067
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
van Montfoort ML; Meijers JC
Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841
[TBL] [Abstract][Full Text] [Related]
25. Coming soon to a pharmacy near you? FXI and FXII inhibitors to prevent or treat thromboembolism.
Cohen O; Ageno W
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):495-505. PubMed ID: 36485148
[TBL] [Abstract][Full Text] [Related]
26. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
27. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
28. Epidemiologic and clinical data linking factors XI and XII to thrombosis.
Key NS
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):66-70. PubMed ID: 25696836
[TBL] [Abstract][Full Text] [Related]
29. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
30. Factor XI as a target for antithrombotic therapy.
Bane CE; Gailani D
Drug Discov Today; 2014 Sep; 19(9):1454-8. PubMed ID: 24886766
[TBL] [Abstract][Full Text] [Related]
31. Factor XI: hemostasis, thrombosis, and antithrombosis.
He R; Chen D; He S
Thromb Res; 2012 May; 129(5):541-50. PubMed ID: 22197449
[TBL] [Abstract][Full Text] [Related]
32. Antithrombotic Agents.
Chan NC; Weitz JI
Circ Res; 2019 Feb; 124(3):426-436. PubMed ID: 30702990
[TBL] [Abstract][Full Text] [Related]
33. Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Büller HR; Bethune C; Bhanot S; Gailani D; Monia BP; Raskob GE; Segers A; Verhamme P; Weitz JI;
N Engl J Med; 2015 Jan; 372(3):232-40. PubMed ID: 25482425
[TBL] [Abstract][Full Text] [Related]
34. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
[TBL] [Abstract][Full Text] [Related]
35. Role of Factor XIa and Plasma Kallikrein in Arterial and Venous Thrombosis.
Visser M; Heitmeier S; Ten Cate H; Spronk HMH
Thromb Haemost; 2020 Jun; 120(6):883-993. PubMed ID: 32375196
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk.
Zhang H; Löwenberg EC; Crosby JR; MacLeod AR; Zhao C; Gao D; Black C; Revenko AS; Meijers JC; Stroes ES; Levi M; Monia BP
Blood; 2010 Nov; 116(22):4684-92. PubMed ID: 20807891
[TBL] [Abstract][Full Text] [Related]
37. Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation.
Gailani D; Broze GJ
Blood; 1993 Aug; 82(3):813-9. PubMed ID: 8338946
[TBL] [Abstract][Full Text] [Related]
38. Differential Roles for the Coagulation Factors XI and XII in Regulating the Physical Biology of Fibrin.
Sylman JL; Daalkhaijav U; Zhang Y; Gray EM; Farhang PA; Chu TT; Zilberman-Rudenko J; Puy C; Tucker EI; Smith SA; Morrissey JH; Walker TW; Nan XL; Gruber A; McCarty OJT
Ann Biomed Eng; 2017 May; 45(5):1328-1340. PubMed ID: 27933406
[TBL] [Abstract][Full Text] [Related]
39. Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis.
Zhong C; Zhang L; Chen L; Deng L; Li R
J Thromb Haemost; 2017 Jan; 15(1):122-130. PubMed ID: 27813324
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of factor XIa as a new approach to anticoagulation.
Schumacher WA; Luettgen JM; Quan ML; Seiffert DA
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):388-92. PubMed ID: 20139363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]